Sidney Kimmel Cancer Center | sciencenewsnet.in

Breaking News

These jacks-of-all-trades are masters, too: Yeast study helps answer age-old biology question

Living with Stage 3 lung cancer in your 80s and 90s

ETRI published Key International Standards for Wearable Healthcare

Study Unveils Balance of AI and Preserving Humanity in Health Care

Press Registration for the ASRS 2024 Annual Scientific Meeting Now Open

A systematic review of three key sugar metabolism proteins, HXK, SnRK1 and TOR, in the regulatory network of plant growth, development and stress

Orchid Welcomes Distinguished Clinical and Genetics Leaders to its Advisory Boards

Potential new worlds rescued by citizens of Earth! Early results of people-powered astronomy project ‘out of this world’

Genetic variations may predispose people to Parkinson’s disease following long-term pesticide exposure, study finds

BIMM University chooses Figshare to showcase its non-traditional research and creative practitioner outputs

25 Apr, 2024

Right Program Could Turn Immune Cells into Cancer Killers

September 9, 2021 sarah JonasResearch Results

Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different “program” that makes them less effective than immune cells in patients whose cancers respond to these immune treatments, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy.

Older Patients Benefit from Cancer Immunotherapies

September 7, 2021 sarah JonasResearch Results

A retrospective analysis of large datasets of biomarkers from tumors and healthy tissue by researchers at the Johns Hopkins Kimmel Cancer Center Convergence Institute suggests that older cancer patients could benefit as much as younger patients from cancer immunotherapies.